acid complex
Recently Published Documents


TOTAL DOCUMENTS

1100
(FIVE YEARS 173)

H-INDEX

52
(FIVE YEARS 8)

RSC Advances ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. 285-296
Author(s):  
Yuan Lin ◽  
Jialian Chen ◽  
Hongzhou Li

The rigid molecular structure of biobased resveratrol/tannic acid (RETA) complex increases the residual amount of RETA-poly(vinyl alcohol) after complete combustion.


Author(s):  
Jianyuan Jing ◽  
Shuiqin Zhang ◽  
Liang Yuan ◽  
Yanting Li ◽  
Yingqiang Zhang ◽  
...  

Author(s):  
Kyriaki S. Pafiti ◽  
Konstantinos-Ioannis Kourtis ◽  
Yiannis Sarigiannis ◽  
Christos C. Petrou ◽  
Manos C. Vlasiou

2021 ◽  
Vol 12 (4) ◽  
Author(s):  
B. Yu. Kovalenko ◽  
V. O. Kovalenko ◽  
D. Yu. Sharylo ◽  
N. V. Polishchuk ◽  
O. A. Korzh ◽  
...  

The paper presents the results of an experiment to assess the effect of different concentrations of vitamin-amino acid complex "Chiktonik" on the growth rate and survival of young African clary catfish (Clarias gariepinus B., 1822) after various stressful situations, for keeping fish in aquaculture. In the experiment, the stressful situation for fish arose due to significant fluctuations in the content of ammonia, nitrites and nitrates in the aquatic environment of a closed recirculation aquasystem, which kept larvae and fry of Clarya catfish during the start of the biological filter, before establishing biological equilibrium in the system. Based on the analysis of sources of scientific and technical information, it was found that the drug "Chiktonik" for more than 10 years is used in animal husbandry to normalize metabolism in animals with unbalanced feeding, after stress, mycotoxin poisoning and antibiotic treatment. This information gave rise to the assumption of the possibility of using the drug in aquaculture, for the same purposes. A series of experiments was performed in a closed recirculating aquasystem, during which the effect of different concentrations of the drug "Chiktonik" in fish feed on larvae and fry of Clarya catfish was tested. It was found that the addition of the drug at the rate of 1 ml per 1 kg of feed accelerates the growth of fish in the experimental variants, compared with the control. Experimental use of high doses of the drug (5, 15, 30 and 45 ml/kg of feed) initially led to inhibition of weight gain of fish, but 10-30 days after the experiment, the growth rate of the experimental material was equal to that of the control group of fish and even exceeded control in the future. The positive effect of vitamin-amino acid complex "Chiktonik" on the survival of young Clarya catfish at the end of the larval period of life and in the early stages of the fry period was established. In an experiment with older fish, which were fully formed fry, such an effect from the use of the drug was not observed: the survival of the fish was at the same level, both in the experiment and in the control. At the same time, it was found that the fry respond less well to high doses of the drug, compared with adult larvae. Thus, the growth rate of fry after the use of high doses of the drug was not equal to that of fish from the control group within a month after the end of the experiment, in contrast to younger fish. In general, the feasibility and safety of the drug "Chiktonik" for young Claria catfish as a feed additive at a dose of 1 ml / kg of fish feed has been proven. It is considered promising to continue research in this direction, using as research material fish of older age groups, including - repair and breeding stock of Claria catfish.


Nutrients ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 4336
Author(s):  
Katherine E. Chetta ◽  
Joseph L. Alcorn ◽  
John E. Baatz ◽  
Carol L. Wagner

Frozen storage is necessary to preserve expressed human milk for critically ill and very preterm infants. Milk pasteurization is essential for donor milk given to this special population. Due to these storage and processing conditions, subtle changes occur in milk nutrients. These changes may have clinical implications. Potentially, bioactive complexes of unknown significance could be found in human milk given to preterm infants. One such complex, a cytotoxic α-lactalbumin-oleic acid complex named “HAMLET,” (Human Alpha-Lactalbumin Made Lethal to Tumor cells) is a folding variant of alpha-lactalbumin that is bound to oleic acid. This complex, isolated from human milk casein, has specific toxicity to both carcinogenic cell lines and immature non-transformed cells. Both HAMLET and free oleic acid trigger similar apoptotic mechanisms in tissue and stimulate inflammation via the NF-κB and MAPK p38 signaling pathways. This protein-lipid complex could potentially trigger various inflammatory pathways with unknown consequences, especially in immature intestinal tissues. The very preterm population is dependent on human milk as a medicinal and broadly bioactive nutriment. Therefore, HAMLET’s possible presence and bioactive role in milk should be addressed in neonatal research. Through a pediatric lens, HAMLET’s discovery, formation and bioactive benefits will be reviewed.


Author(s):  
Hsiao‐Chi Wang ◽  
Chii‐Shyan Wang ◽  
Shu‐Chen Hsieh ◽  
Yu‐Ting Hung ◽  
Hsuan‐Hsiang Chen

Sign in / Sign up

Export Citation Format

Share Document